On 14 Oct 2019, Hoth Therapeutics Inc (NASDAQ: HOTH) stock traded volume of 11,072 shares during its last trading session as compared to its average volume of 10009 shares over the recent month. HOTH ended its day with the above stream along the move of 1.3% and closed at the price of $4.25 before opening at $4.3. It has total market capitalization is $42783560. 52-week range of the stock remained $ 3.83 – 13.88 while its day lowest price was $4.1 and its hit its day highest price at $4.47.
Hoth Therapeutics, Inc. (HOTH) recently reported that the company has made a donation to the National Eczema Association in order to bring continued awareness to National Eczema Awareness Month this October.
“Atopic Dermatitis is a widespread affliction that affects millions of people globally,” stated Mr. Robb Knie, Chief Executive Officer of Hoth Therapeutics. “We are proud to continue our efforts to bring awareness to this this incredibly important health matter. Going forward, we will continue to leverage our relationships with our renowned joint ventures in the healthcare industry as we strive to enhance the lives of those that are afflicted with this disease. We look forward to continuing the development and progress of our proprietary BioLexa Platform, which is presently progressing through clinical trials and shows encouraging results in the process.”
Hoth’s BioLexa Platform is a proprietary antimicrobial therapy. The Company intends to explore the use of the BioLexa Platform for the treatment of atopic dermatitis, or eczema. It also focuses on exploring the use of the BioLexa Platform in the aesthetic dermatology field to help treat and reduce post-procedure infections, accelerate healing and improve clinical outcomes for patients undergoing procedures.
HOTH plunged -4.72% in past week and declined -20.52% in one month. During the past three-month period the stock dropped -10.17% and decreased -23.19% in past six month while year to date performance of -50.29%.